+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Point of Care (PoC) Molecular Diagnostics Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • PDF Icon

    Report

  • 146 Pages
  • October 2023
  • Region: Global
  • OG Analysis
  • ID: 5147629
UP TO OFF until May 31st 2024
The study predicts the short term and long term trends that can shape up the future of the Point of Care (PoC) Molecular Diagnostics market including the COVID-19 pandemic implications for Point of Care (PoC) Molecular Diagnostics industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.

The Point of Care (PoC) Molecular Diagnostics market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Point of Care (PoC) Molecular Diagnostics Companies are focusing on improving efficiency and containing costs in current economically challenging conditions. Point of Care (PoC) Molecular Diagnostics market forecast and Point of Care (PoC) Molecular Diagnostics market growth is outlook through 2030.

The report reflects on predictions with 2022 as the base year and 2023-2030 as the forecast period. The research was based on the findings of expert team of analysts analyzing the Point of Care (PoC) Molecular Diagnostics market opportunities, underlying market factors, demographic and economic factors, market developments and others.

Point of Care (PoC) Molecular Diagnostics industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening Point of Care (PoC) Molecular Diagnostics market share in developed countries.

Scope of the research

Global Point of Care (PoC) Molecular Diagnostics Market is analyzed and forecast over the outlook period from 2023 to 2030 By application including

  • Infectious Diseases
  • Oncology
  • Hematology
  • Prenatal Testing
  • Endocrinology
  • Others

Global Point of Care (PoC) Molecular Diagnostics Market is analyzed and forecast over the outlook period from 2023 to 2030 By technology including

  • PCR Based
  • Genetic Sequencing Based
  • Hybridization Based
  • Microarray Based

Global Point of Care (PoC) Molecular Diagnostics Market is analyzed and forecast over the outlook period from 2023 to 2030 By End User including

  • Laboratories
  • Hospitals
  • Homecare
  • Others
Top Companies Operating in Point of Care (PoC) Molecular Diagnostics market include-Abaxis, Abbott Laboratories, Alere Inc, Bayer Healthcare, BioMerieux, Bio-Rad Laboratories, Dako, Danaher Corporation, Nipro Diagnostics, Nova Biomedical


This product will be delivered within 1-3 business days.

Table of Contents

1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Executive Summary
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Point of Care (PoC) Molecular Diagnostics Market-Key Findings, 2022
3. Strategic Imperatives on Global Point of Care (PoC) Molecular Diagnostics Market
3.1 COVID-19 Impact Analysis
3.2 Market Trends-Across Types, Applications, End User Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Point of Care (PoC) Molecular Diagnostics Companies
4. Global Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2030 Outlook by Application
4.1 Infectious Diseases
4.2 Oncology
4.3 Hematology
4.4 Prenatal Testing
4.5 Endocrinology
4.6 Others
5. Global Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2030 Outlook by Technology
5.1 PCR Based
5.2 Genetic Sequencing Bassed
5.3 Hybridization Based
5.4 Microarray Based
6. Global Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2030 Outlook by End User
6.1 Laboratories
6.2 Hospitals
6.3 Homecare
6.4 Others
7 Asia Pacific Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2030
7.1 Leading Point of Care (PoC) Molecular Diagnostics Types contributing to Asia Pacific market
7.2 Top Applications contributing to Asia Pacific Point of Care (PoC) Molecular Diagnostics
7.3 Top countries contributing to Asia Pacific Point of Care (PoC) Molecular Diagnostics
8 Europe Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2030
8.1 Leading Point of Care (PoC) Molecular Diagnostics Types contributing to Europe market
8.2 Top Applications contributing to Europe Point of Care (PoC) Molecular Diagnostics
8.3 Top countries contributing to Europe Point of Care (PoC) Molecular Diagnostics
9 North America Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2030
9.1 Leading Point of Care (PoC) Molecular Diagnostics Types contributing to North America market
9.2 Top Applications contributing to North America Point of Care (PoC) Molecular Diagnostics
9.3 Top countries contributing to North America Point of Care (PoC) Molecular Diagnostics
10 South and Central America Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2030
10.1 Leading Point of Care (PoC) Molecular Diagnostics Types contributing to South and Central America market
10.2 Top Applications contributing to South and Central America Point of Care (PoC) Molecular Diagnostics
10.3 Top countries contributing to South and Central America Point of Care (PoC) Molecular Diagnostics
11 Middle East Africa Point of Care (PoC) Molecular Diagnostics Market Value Outlook to 2030
11.1 Leading Point of Care (PoC) Molecular Diagnostics Types contributing to Middle East Africa market
11.2 Top Applications contributing to Middle East Africa Point of Care (PoC) Molecular Diagnostics
11.3 Top countries contributing to Middle East Africa Point of Care (PoC) Molecular Diagnostics
12 Business Profiles of Leading Companies
12.1 Business Description, SWOT and Financial Analysis of Companies in Point of Care (PoC) Molecular Diagnostics market
12.2 Abaxis
12.3 Abbott Laboratories
12.4 Alere Inc
12.5 Bayer Healthcare
12.6 BioMerieux
12.7 Bio-Rad Laboratories
12.8 Dako
12.9 Danaher Corporation
12.10 Nipro Diagnostics
12.11 Nova Biomedical
13 Recent Industry Developments
14 Appendix
14.1 Analyst's Expertise
14.2 Sources and Methodology
14.3 Contacts

Companies Mentioned

  • Abaxis
  • Abbott Laboratories
  • Alere Inc
  • Bayer Healthcare
  • Biomerieux
  • Bio-Rad Laboratories
  • Dako
  • Danaher Corporation
  • Nipro Diagnostics
  • Nova Biomedical

Methodology

Loading
LOADING...